Market Forecast by Regions and Countries (North America, Europe, LATAM, Middle East, Asia Pacific and Africa), By Type (10 mg Tablet, 20 mg Tablet), By Application (Treatment of angina pectoris, Others) And Competitive Landscape
Product Code: ETC13237913 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 | |
According to 6Wresearch internal database and industry insights, the Global Isosorbide Mononitrate Market was valued at approximately USD 1.2 billion in 2024 and is projected to reach USD 1.85 billion by 2031, growing at a CAGR of 5.8% during the forecast period of 2025-2031.
Report Name | Global Isosorbide Mononitrate Market |
Forecast Period | 2025 - 2031 |
CAGR | 5.8% |
Market Size | USD 1.85 billion by 2031 |
Growing Sector | Pharmaceutical |
The Global Isosorbide Mononitrate Market report thoroughly covers the market by regions, type, and application. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high-growth areas, and market drivers, which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The Global Isosorbide Mononitrate Market has been growing steadily, driven by its widespread use in the pharmaceutical sector, particularly in the treatment of angina pectoris and other heart-related conditions. With the increasing prevalence of cardiovascular diseases globally, the demand for isosorbide mononitrate continues to rise. The market has also benefited from advancements in drug delivery mechanisms and therapeutic formulations, broadening the application scope of this compound.
The Global Isosorbide Mononitrate Market is projected to experience robust growth with a CAGR of 5.8% during the forecast period of 2025-2031. Several factors contribute to the robust Global Isosorbide Mononitrate Market Growth witnessed in recent years. Chief among these is the increasing burden of health disorders such as hypertension, which necessitate long-term therapeutic solutions. Furthermore, growing geriatric populations worldwide have created a significant demand for effective and affordable cardiac medications, wherein isosorbide mononitrate plays a key role. Heightened awareness about preventive healthcare and favorable reimbursement policies have also spurred market growth. Pharmaceutical companies' focus on developing innovative and patient-compliant formulations further proves integral to driving this market.
Despite its promising growth trajectory, the Global Isosorbide Mononitrate Industry faces certain critical challenges. One major hurdle is the availability of alternative treatments and competing drugs in the market, which impact the adoption rates of isosorbide mononitrate. Additionally, stringent regulatory requirements and clinical trials in various regions can increase the time and cost required to introduce new products. Fluctuating raw material costs and supply chain disruptions, particularly in light of recent global events, also pose significant challenges to manufacturers and key stakeholders.
Emerging trends in the Global Isosorbide Mononitrate Market have the potential to reshape its landscape in the future. One notable trend is the shift towards personalized medicine, which enables tailored therapy using isosorbide mononitrate for specific patient needs, increasing its efficacy. Advanced drug delivery systems, such as transdermal patches and oral disintegrating tablets, are gaining traction for their ability to improve patient compliance. Additionally, the growing popularity of generic medications has opened avenues for new market players to enter and expand their foothold in this sector.
The increasing demand for isosorbide mononitrate provides substantial investment opportunities for both established and emerging pharmaceutical companies. Strategic collaborations for drug development and regional market expansion have become prevalent. Investors can also explore opportunities in advancing manufacturing technologies to enhance production efficiency and reduce costs. Furthermore, the emphasis on expanding into untapped regions, particularly in developing countries, provides a lucrative platform for industry growth and partnerships.
The market is dominated by several key players who have established their presence through innovative research, robust distribution networks, and partnerships. Companies such as Merck & Co., Inc., Novartis AG, and Teva Pharmaceutical Industries Ltd. hold significant Global Isosorbide Mononitrate Market Share due to their expansive product portfolios and market reach.
Government regulations play a pivotal role in shaping the trajectory of the market. Regulatory authorities like the FDA, EMA, and others enforce stringent guidelines pertaining to the approval, manufacturing, and marketing of isosorbide mononitrate-based drugs. These guidelines ensure the safety and efficacy of the compound but also present compliance challenges for pharmaceutical manufacturers. Recent initiatives aimed at streamlining drug approval processes, as well as government support for generic formulations, are expected to benefit market growth significantly.
The future of the Global Isosorbide Mononitrate Market appears promising, with increasing advancements in pharmaceutical technologies and the rising need for cardiac medications. Opportunities in emerging markets, coupled with the expansion of healthcare infrastructure, will likely drive substantial market growth. Research focusing on improving therapeutic effectiveness and patient compliance is expected to lead to the development of breakthrough formulations. Overall, the market is positioned as a critical component in addressing the growing global demand for heart disease management.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
The 20 mg tablet segment is expected to dominate the global isosorbide mononitrate market in the coming years, primarily due to its efficacy in treating severe cases of angina pectoris and its growing adoption worldwide. Patients and healthcare providers favor the 20 mg dosage for its sustained release and prolonged therapeutic effect, reducing the frequency of dosing.
The treatment of angina pectoris segment is anticipated to remain dominant, driven by the rising burden of cardiac disorders globally. With an aging population, lifestyle factors such as physical inactivity, unhealthy diets, and stress have contributed to a greater incidence of conditions like angina, thereby increasing demand for isosorbide mononitrate as a treatment solution.
According to Nia, Senior Research Analyst, 6Wresearch, North America is anticipated to dominate the market in the coming years. This is primarily driven by the aging population and the high incidence of cardiovascular conditions such as angina pectoris and hypertension in the region.
The Market Report includes the following segments:
Global Isosorbide Mononitrate Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Isosorbide Mononitrate Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Isosorbide Mononitrate Market Revenues & Volume, 2021 & 2031F |
3.3 Global Isosorbide Mononitrate Market - Industry Life Cycle |
3.4 Global Isosorbide Mononitrate Market - Porter's Five Forces |
3.5 Global Isosorbide Mononitrate Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Isosorbide Mononitrate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Isosorbide Mononitrate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Isosorbide Mononitrate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Isosorbide Mononitrate Market Trends |
6 Global Isosorbide Mononitrate Market, 2021 - 2031 |
6.1 Global Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Isosorbide Mononitrate Market, Revenues & Volume, By 10 mg Tablet, 2021 - 2031 |
6.1.3 Global Isosorbide Mononitrate Market, Revenues & Volume, By 20 mg Tablet, 2021 - 2031 |
6.2 Global Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Isosorbide Mononitrate Market, Revenues & Volume, By Treatment of angina pectoris, 2021 - 2031 |
6.2.3 Global Isosorbide Mononitrate Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Isosorbide Mononitrate Market, Overview & Analysis |
7.1 North America Isosorbide Mononitrate Market Revenues & Volume, 2021 - 2031 |
7.2 North America Isosorbide Mononitrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Isosorbide Mononitrate Market, Overview & Analysis |
8.1 Latin America (LATAM) Isosorbide Mononitrate Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Isosorbide Mononitrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Isosorbide Mononitrate Market, Overview & Analysis |
9.1 Asia Isosorbide Mononitrate Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Isosorbide Mononitrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Isosorbide Mononitrate Market, Overview & Analysis |
10.1 Africa Isosorbide Mononitrate Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Isosorbide Mononitrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Isosorbide Mononitrate Market, Overview & Analysis |
11.1 Europe Isosorbide Mononitrate Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Isosorbide Mononitrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Isosorbide Mononitrate Market, Overview & Analysis |
12.1 Middle East Isosorbide Mononitrate Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Isosorbide Mononitrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Isosorbide Mononitrate Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Isosorbide Mononitrate Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Isosorbide Mononitrate Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Isosorbide Mononitrate Market Key Performance Indicators |
14 Global Isosorbide Mononitrate Market - Export/Import By Countries Assessment |
15 Global Isosorbide Mononitrate Market - Opportunity Assessment |
15.1 Global Isosorbide Mononitrate Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Isosorbide Mononitrate Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Isosorbide Mononitrate Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Isosorbide Mononitrate Market - Competitive Landscape |
16.1 Global Isosorbide Mononitrate Market Revenue Share, By Companies, 2024 |
16.2 Global Isosorbide Mononitrate Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |